The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. HigginsMRC Biostatistics Unit, Institute of Public Health, Cambridge CB2 0SR, UK. [email protected]Doug AltmanCentre for Statistics in Medicine, University of Oxford, Oxford, UKPeter C GøtzscheThe Nordic Cochrane Centre, Rigshospitalet and University of Copenhagen, DenmarkPeter JüniInstitute of Social and Preventive Medicine, University of Bern, SwitzerlandDavid MoherClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, CanadaAndrew D OxmanPreventive and International Health Care Unit, Norwegian Knowledge Centre for the Health Services, Oslo, NorwayJelena SavovićDepartment of Social Medicine, University of Bristol, Bristol, UKKenneth F. SchulzFHI, Research Triangle Park, North Carolina, USALaura WeeksClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, CanadaJonathan A C SterneDepartment of Social Medicine, University of Bristol, Bristol, UKCochrane Bias Methods GroupCochrane Statistical Methods Group
2011en
ABI
Annotatsiya
Flaws in the design, conduct, analysis, and reporting of randomised trials can cause the effect of an intervention to be underestimated or overestimated. The Cochrane Collaboration’s tool for assessing risk of bias aims to make the process clearer and more accurate
Hali tarjima qilinmagan
Identifikatorlar
Iqtiboslar va manbalar
9 ta iqtibos0 ta foydalanilgan manba